De novo production of the flavonoid naringenin in engineered Saccharomyces cerevisiae

被引:261
|
作者
Koopman, Frank [1 ,2 ,3 ]
Beekwilder, Jules [2 ,4 ,5 ]
Crimi, Barbara [1 ,2 ,3 ]
van Houwelingen, Adele [4 ]
Hall, Robert D. [2 ,4 ,5 ]
Bosch, Dirk [2 ,4 ,5 ]
van Maris, Antonius J. A. [1 ,3 ]
Pronk, Jack T. [1 ,2 ,3 ]
Daran, Jean-Marc [1 ,2 ,3 ]
机构
[1] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands
[2] Platform Green Synthet Biol, NL-2600 GA Delft, Netherlands
[3] Kluyver Ctr Genom Ind Fermentat, NL-2600 GA Delft, Netherlands
[4] Plant Res Int, NL-6700 AA Wageningen, Netherlands
[5] Ctr Biosyst Genom, NL-6700 AB Wageningen, Netherlands
关键词
Saccharomyces cerevisiae; Naringenin; de novo; Flavonoids; Metabolic engineering; TYROSINE AMMONIA-LYASE; ESCHERICHIA-COLI; IN-VIVO; BIOSYNTHESIS; YEAST; EXPRESSION; ARABIDOPSIS; GENE; PATHWAY; GENOME;
D O I
10.1186/1475-2859-11-155
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Flavonoids comprise a large family of secondary plant metabolic intermediates that exhibit a wide variety of antioxidant and human health-related properties. Plant production of flavonoids is limited by the low productivity and the complexity of the recovered flavonoids. Thus to overcome these limitations, metabolic engineering of specific pathway in microbial systems have been envisaged to produce high quantity of a single molecules. Result: Saccharomyces cerevisiae was engineered to produce the key intermediate flavonoid, naringenin, solely from glucose. For this, specific naringenin biosynthesis genes from Arabidopsis thaliana were selected by comparative expression profiling and introduced in S. cerevisiae. The sole expression of these A. thaliana genes yielded low extracellular naringenin concentrations (<5.5 mu M). To optimize naringenin titers, a yeast chassis strain was developed. Synthesis of aromatic amino acids was deregulated by alleviating feedback inhibition of 3-deoxy-d-arabinose-heptulosonate-7-phosphate synthase (Aro3, Aro4) and byproduct formation was reduced by eliminating phenylpyruvate decarboxylase (Aro10, Pdc5, Pdc6). Together with an increased copy number of the chalcone synthase gene and expression of a heterologous tyrosine ammonia lyase, these modifications resulted in a 40 fold increase of extracellular naringenin titers (to approximately 200 mu M) in glucose-grown shake flask cultures. In aerated, pH controlled batch reactors, extracellular naringenin concentrations of over 400 mu M were reached. Conclusion: The results reported in this study demonstrate that S. cerevisiae is capable of de novo production of naringenin by coexpressing the naringenin production genes from A. thaliana and optimization of the flux towards the naringenin pathway. The engineered yeast naringenin production host provides a metabolic chassis for production of a wide range of flavonoids and exploration of their biological functions.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Engineering Saccharomyces cerevisiae for the production of dihydroquercetin from naringenin
    Yu, Shiqin
    Li, Mingjia
    Gao, Song
    Zhou, Jingwen
    MICROBIAL CELL FACTORIES, 2022, 21 (01)
  • [22] Engineering Saccharomyces cerevisiae for the production of dihydroquercetin from naringenin
    Shiqin Yu
    Mingjia Li
    Song Gao
    Jingwen Zhou
    Microbial Cell Factories, 21
  • [23] De Novo Biosynthesis of Curcumin in Saccharomyces cerevisiae
    Rainha, Joao
    Rodrigues, Joana L.
    Rodrigues, Ligia R.
    ACS SYNTHETIC BIOLOGY, 2024, 13 (06): : 1727 - 1736
  • [24] De novo biosynthesis of anthocyanins in Saccharomyces cerevisiae
    Eichenberger, Michael
    Hansson, Anders
    Fischer, David
    Duerr, Lara
    Naesby, Michael
    FEMS YEAST RESEARCH, 2018, 18 (04)
  • [25] De novo biosynthesis of liquiritin in Saccharomyces cerevisiae
    Yin, Yan
    Li, Yanpeng
    Jiang, Dan
    Zhang, Xianan
    Gao, Wei
    Liu, Chunsheng
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (04) : 711 - 721
  • [26] De novo biosynthesis of liquiritin in Saccharomyces cerevisiae
    Yan Yin
    Yanpeng Li
    Dan Jiang
    Xianan Zhang
    Wei Gao
    Chunsheng Liu
    Acta Pharmaceutica Sinica B, 2020, 10 (04) : 711 - 721
  • [27] De Novo Biosynthesis of Dihydroquercetin in Saccharomyces cerevisiae
    Li, Hongbiao
    Zhang, Shuai
    Dong, Zilong
    Shan, Xiaoyu
    Zhou, Jingwen
    Zeng, Weizhu
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2024, 72 (35) : 19436 - 19446
  • [28] De Novo Biosynthesis of Polydatin in Saccharomyces cerevisiae
    Liu, Tian
    Liu, Yuqian
    Li, Lan
    Liu, Xiaonan
    Guo, Zhaokuan
    Cheng, Jian
    Zhu, Xiaoxi
    Lu, Lina
    Zhang, Junlin
    Fan, Guanwei
    Xie, Nengzhong
    Lu, Jian
    Jiang, Huifeng
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2021, 69 (21) : 5917 - 5925
  • [29] De Novo Synthesis of Chrysin in Saccharomyces cerevisiae
    Xu, Weiqi
    Liu, Mengsu
    Li, Hongbiao
    Chen, Jian
    Zhou, Jingwen
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2024, 72 (12) : 6481 - 6490
  • [30] Establishment of Saccharomyces cerevisiae as a cell factory for efficient de novo production of monogalactosyldiacylglycerol
    Gu, Xiaosong
    Shi, Yumei
    Luo, Changxin
    Cheng, Jintao
    BIOTECHNOLOGY FOR BIOFUELS AND BIOPRODUCTS, 2024, 17 (01):